Serum levels of adipokines resistin and leptin in patients with colon cancer
2010

Serum Levels of Adipokines in Colon Cancer Patients

Sample size: 56 publication Evidence: moderate

Author Information

Author(s): Sălăgeanu A, Tucureanu C, Lerescu L, Caraş I, Pitica R, Gangura G, Costea R, Neagu S

Primary Institution: National Institute for Research and Development in Microbiology and Immunology ‘Cantacuzino’

Hypothesis

The study investigates the association between blood adipocytokine levels and clinicopathological characteristics of colon cancer patients undergoing surgery.

Conclusion

The study found that resistin levels were significantly higher and leptin levels were significantly lower in colon cancer patients compared to healthy controls.

Supporting Evidence

  • Resistin levels were significantly higher in colon cancer patients compared to controls.
  • Leptin levels were significantly lower in colon cancer patients compared to controls.
  • Leptin levels decreased gradually with tumor stage and aggressiveness.
  • A significant negative correlation was found between leptin and T stage.

Takeaway

This study looked at two substances in the blood, resistin and leptin, to see how they relate to colon cancer. They found that people with colon cancer had more resistin and less leptin than healthy people.

Methodology

The study measured serum levels of adipokines in 29 colon cancer patients and 27 healthy volunteers using multianalyte xMap profiling technology.

Limitations

The study had a limited number of patients in advanced stages of disease and lacked information on body weight changes prior to sampling.

Participant Demographics

Patients included 29 colon cancer patients and 27 healthy volunteers, with no significant difference in age and sex between groups.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication